People taking GLP-1 meds could see costs drop in 2026, thanks to a new federal deal with Eli Lilly and Novo Nordisk, the ...
Pfizer Inc. has submitted a sweetened bid for obesity drug startup Metsera Inc. as its fight against rival Novo Nordisk A/S continues to escalate, according to people familiar with the matter.
"Trump's meltdown unfolds as a fiery clapback rattles him to the core, leading to a desperate attempt to salvage his dignity, only to ...
Pfizer has submitted a sweetened bid for obesity drug developer Metsera , as its fight against rival Novo Nordisk escalates, ...
Donald Trump hailed his deal to slash the price of blockbuster weight loss drugs as a game changer. But major gaps in the ...
Gordon Findlay is a Novo Nordisk manager based in Switzerland who didn’t attend the White House’s Nov. 6 drug pricing announcement. Robert F. Kennedy Jr. wasn’t fleeing the scene, a White House ...
The event put on by the Triangle East Chamber of Commerce with Johnston County Schools and Johnston Community College ...
There’s a lot of buzz about the popular GLP-1 weight loss drugs after President Donald Trump announced this week a deal with ...
A viral video circulated online in November 2025 that purported to show the United States Secretary of the Department of ...
(Reuters) -Novo Nordisk expects global sales to decline by low-single-digit percentage in 2026 after the drugmaker unveiled a ...
4hon MSN
Health Care Roundup: Market Talk
Find insight on Eli Lilly, Novo Nordisk, AstraZeneca, Hikma Pharmaceuticals in the latest Market Talks covering the Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results